Skip to main content
Top
Published in: World Journal of Emergency Surgery 1/2017

Open Access 01-12-2017 | Methodology

Early recognition of methicillin-resistant Staphylococcus aureus surgical site infections using risk and protective factors identified by a group of Italian surgeons through Delphi method

Authors: G. Sganga, C. Tascini, E. Sozio, S. Colizza

Published in: World Journal of Emergency Surgery | Issue 1/2017

Login to get access

Abstract

Background

Surgical site infections (SSIs) constitute a major clinical problem in terms of morbidity, mortality, duration of hospital stay, and overall costs. The bacterial pathogens implicated most frequently are Streptococcus pyogenes (S. pyogenes) and Staphylococcus aureus (S. aureus). The incidence of methicillin-resistant S. aureus (MRSA) SSIs is increasing significantly. Since these infections have a significant impact on hospital budgets and patients’ health, their diagnosis must be anticipated and therapy improved. The first step should be to evaluate risk factors for MRSA SSIs.

Methods

Through a literature review, we identified possible major and minor risk factors for, and protective factors against MRSA SSIs. We then submitted statements on these factors to 228 Italian surgeons to determine, using the Delphi method, the degree of consensus regarding their importance. The consensus was rated as positive if >80% of the voters agreed with a statement and as negative if >80% of the voters disagreed. In other cases, no consensus was reached.

Results

There was positive consensus that sepsis, >2 weeks of hospitalization, age >75 years, colonization by MRSA, and diabetes were major risk factors for MRSA SSIs. Other possible major risk factors, on which a consensus was not reached, e.g., prior antibiotic use, were considered minor risk factors. Other minor risk factors were identified. An adequate antibiotic prophylaxis, laparoscopic technique, and infection committee surveillance were considered protective factors against MRSA SSIs. All these factors might be used to build predictive criteria for identifying SSI due to MRSA.

Conclusions

In order to help to recognize and thus promptly initiate an adequate antibiotic therapy for MRSA SSIs, we designed a gradation of risk and protective factors. Validation, ideally prospective, of this score is now required. In the case of a SSI, if the risk that the infection is caused by MRSA is high, empiric antibiotic therapy should be started after debriding the wound and collecting material for culture.
Literature
2.
go back to reference Astagneau P, Rioux C, Golliot F, Brucker G, for the INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001;48:267–74.CrossRefPubMed Astagneau P, Rioux C, Golliot F, Brucker G, for the INCISO Network Study Group. Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001;48:267–74.CrossRefPubMed
3.
go back to reference Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.CrossRefPubMed Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.CrossRefPubMed
4.
go back to reference Leaper DJ, Van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, Berger A. Surgical site infection—a European perspective of incidence and economic burden. Int Wound J. 2004;1:247–73.CrossRefPubMed Leaper DJ, Van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, Berger A. Surgical site infection—a European perspective of incidence and economic burden. Int Wound J. 2004;1:247–73.CrossRefPubMed
5.
go back to reference Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The second national prevalence survey of infection in hospitals–overview of the results. J Hosp Infect. 1996;32:175–90.CrossRefPubMed Emmerson AM, Enstone JE, Griffin M, Kelsey MC, Smyth ET. The second national prevalence survey of infection in hospitals–overview of the results. J Hosp Infect. 1996;32:175–90.CrossRefPubMed
6.
go back to reference Greco D, Moro ML, Tozzi AE, De Giacomi GV. Effectiveness of an intervention program in reducing postoperative infections. Infection. 2003;31(Suppl 2):164–9. Greco D, Moro ML, Tozzi AE, De Giacomi GV. Effectiveness of an intervention program in reducing postoperative infections. Infection. 2003;31(Suppl 2):164–9.
7.
go back to reference Nicastri E, Petrosillo N, Martini L, Larosa M, Gesu GP, Ippolito G, the INF NOS Study Group. Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalence study for the INF- NOS Project. Infection. 2003;31(2):16–22. Nicastri E, Petrosillo N, Martini L, Larosa M, Gesu GP, Ippolito G, the INF NOS Study Group. Prevalence of nosocomial infections in 15 Italian hospitals: first point prevalence study for the INF- NOS Project. Infection. 2003;31(2):16–22.
8.
go back to reference Sganga G, Tascini C, Sozio E, Carlini M, Chirletti P, Cortese F, et al. Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant Staphylococcus aureus surgical site infections and a position paper on associated risk factors: the perspective of an Italian group of surgeons. World J Emerg Surg. 2016;11:26.CrossRefPubMedPubMedCentral Sganga G, Tascini C, Sozio E, Carlini M, Chirletti P, Cortese F, et al. Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant Staphylococcus aureus surgical site infections and a position paper on associated risk factors: the perspective of an Italian group of surgeons. World J Emerg Surg. 2016;11:26.CrossRefPubMedPubMedCentral
9.
go back to reference Sganga G, Brisinda G, Castagneto M. Practical aspects of antibiotic prophylaxis in high-risk surgical patients. In: Van Saene HKF, Sganga G, Silvestri L, editors. Infection in the critically Ill: an ongoing challenge. Berlin: Springer Verlag; 2001. p. 47–58.CrossRef Sganga G, Brisinda G, Castagneto M. Practical aspects of antibiotic prophylaxis in high-risk surgical patients. In: Van Saene HKF, Sganga G, Silvestri L, editors. Infection in the critically Ill: an ongoing challenge. Berlin: Springer Verlag; 2001. p. 47–58.CrossRef
10.
go back to reference Howard RJ, Simmons RL. Surgical infectious diseases. Norwalk: Appleton and Lange; 1988. Howard RJ, Simmons RL. Surgical infectious diseases. Norwalk: Appleton and Lange; 1988.
11.
go back to reference ECDC Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011-2012. www.ecdc.europa.eu. ECDC Surveillance Report. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011-2012. www.​ecdc.​europa.​eu.
12.
go back to reference Sganga G. New perspectives in antibiotic prophylaxis for intra-abdominal surgery. J Hosp Infect. 2002;50:S17–21.CrossRefPubMed Sganga G. New perspectives in antibiotic prophylaxis for intra-abdominal surgery. J Hosp Infect. 2002;50:S17–21.CrossRefPubMed
13.
go back to reference Petrosillo N, Drapeau CM, Nicastri E, Martini L, Ippolito G, Moro ML. ANIPIO. Surgical site infections in Italian Hospitals: a prospective multicenter study. BMC Infect Dis. 2008;8:34.CrossRefPubMedPubMedCentral Petrosillo N, Drapeau CM, Nicastri E, Martini L, Ippolito G, Moro ML. ANIPIO. Surgical site infections in Italian Hospitals: a prospective multicenter study. BMC Infect Dis. 2008;8:34.CrossRefPubMedPubMedCentral
14.
go back to reference Fiorio M, Marvaso A, Viganò F, Marchetti F. Incidence of surgical site infections in general surgery in Italy. Infection. 2006;34:310–4.CrossRefPubMed Fiorio M, Marvaso A, Viganò F, Marchetti F. Incidence of surgical site infections in general surgery in Italy. Infection. 2006;34:310–4.CrossRefPubMed
15.
go back to reference Prospero E, Cavicchi A, Bacelli S, Barbadoro P, Tantucci L, D’Errico MM. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol. 2006;27:1313–7.CrossRefPubMed Prospero E, Cavicchi A, Bacelli S, Barbadoro P, Tantucci L, D’Errico MM. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol. 2006;27:1313–7.CrossRefPubMed
16.
go back to reference Marchi M, Pan A, Gagliotti C, Morsillo F, Parenti M, Resi D, Moro ML, Sorveglianza Nazionale Infezioni in Chirurgia (SNICh) Study Group. The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. Euro Surveill. 2014;29:19. Marchi M, Pan A, Gagliotti C, Morsillo F, Parenti M, Resi D, Moro ML, Sorveglianza Nazionale Infezioni in Chirurgia (SNICh) Study Group. The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011. Euro Surveill. 2014;29:19.
17.
go back to reference Delgado-Rodriguez M, Gomez-Ortega A, Sillero-Arenas M, Liorca J. Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol. 2001;22:24–30.CrossRefPubMed Delgado-Rodriguez M, Gomez-Ortega A, Sillero-Arenas M, Liorca J. Epidemiology of surgical-site infections diagnosed after hospital discharge: a prospective cohort study. Infect Control Hosp Epidemiol. 2001;22:24–30.CrossRefPubMed
18.
go back to reference Brandt C, Sohr D, Behnke M, Daschner F, Ruden H, Gastmeier P. Reduction of surgical site infection rates associated with active surveillance. Infect Control Hosp Epidemiol. 2006;27:1347–51.CrossRefPubMed Brandt C, Sohr D, Behnke M, Daschner F, Ruden H, Gastmeier P. Reduction of surgical site infection rates associated with active surveillance. Infect Control Hosp Epidemiol. 2006;27:1347–51.CrossRefPubMed
19.
go back to reference Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–8.CrossRefPubMed Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606–8.CrossRefPubMed
20.
go back to reference National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85.
21.
go back to reference Altemeier WA, Culbertson WR, Hummel RP. Surgical considerations of endogenous infections sources, types, and methods of control. Surg Clin North Am. 1968;48:227–40.CrossRefPubMed Altemeier WA, Culbertson WR, Hummel RP. Surgical considerations of endogenous infections sources, types, and methods of control. Surg Clin North Am. 1968;48:227–40.CrossRefPubMed
22.
go back to reference Wiley AM, Ha’eri GB. Routes of infection: a study of using “tracer particles” in the orthopedic operating room. Clin Orthop. 1979;139:150–5. Wiley AM, Ha’eri GB. Routes of infection: a study of using “tracer particles” in the orthopedic operating room. Clin Orthop. 1979;139:150–5.
23.
go back to reference Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–78.CrossRefPubMed Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–78.CrossRefPubMed
24.
go back to reference Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13:1840–6.CrossRefPubMedPubMedCentral Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007;13:1840–6.CrossRefPubMedPubMedCentral
25.
go back to reference Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attribut- able to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–8.CrossRefPubMed Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attribut- able to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–8.CrossRefPubMed
26.
go back to reference Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999;5:9–17.CrossRefPubMedPubMedCentral Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999;5:9–17.CrossRefPubMedPubMedCentral
27.
go back to reference Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V. Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control. 2010;38:112–20.CrossRefPubMed Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V. Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control. 2010;38:112–20.CrossRefPubMed
28.
go back to reference Albrich W, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008;8:289–301.CrossRefPubMed Albrich W, Harbarth S. Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis. 2008;8:289–301.CrossRefPubMed
29.
go back to reference Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166–74.CrossRefPubMed Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166–74.CrossRefPubMed
30.
go back to reference Gastmeier P, Schwab F, Sohr D, Behnke M, Geffers C. Reproducibility of the surveillance effect to decrease nosocomial infection rates. Infect Control Hosp Epidemiol. 2009;30:993–9.CrossRefPubMed Gastmeier P, Schwab F, Sohr D, Behnke M, Geffers C. Reproducibility of the surveillance effect to decrease nosocomial infection rates. Infect Control Hosp Epidemiol. 2009;30:993–9.CrossRefPubMed
31.
go back to reference Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ. Update on screening and clinical diagnosis of methicillin-resistante Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2011;37:110–7.CrossRefPubMed Harbarth S, Hawkey PM, Tenover F, Stefani S, Pantosti A, Struelens MJ. Update on screening and clinical diagnosis of methicillin-resistante Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2011;37:110–7.CrossRefPubMed
32.
go back to reference Long SW, Olsen RJ, Mehta SC, Palzkill T, Cernoch PL, Perez KK, et al. PBP2a mutations causing high-level ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2014;58:6668–74.CrossRefPubMedPubMedCentral Long SW, Olsen RJ, Mehta SC, Palzkill T, Cernoch PL, Perez KK, et al. PBP2a mutations causing high-level ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2014;58:6668–74.CrossRefPubMedPubMedCentral
33.
go back to reference Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:e10–52.CrossRefPubMed Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59:e10–52.CrossRefPubMed
35.
go back to reference Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169–79.CrossRefPubMed Boucher HW, Wilcox M, Talbot GH, Puttagunta S, Das AF, Dunne MW. Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169–79.CrossRefPubMed
36.
go back to reference Fernández J, Greenwood-Quaintance KE, Patel R. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections. Diagn Microbiol Infect Dis. 2016;85:449–51.CrossRefPubMed Fernández J, Greenwood-Quaintance KE, Patel R. In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections. Diagn Microbiol Infect Dis. 2016;85:449–51.CrossRefPubMed
37.
go back to reference Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis. 2016;62:545–61.CrossRefPubMed Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J. A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis. 2016;62:545–61.CrossRefPubMed
39.
go back to reference Dixon E, Armstrong C, Maddern G, Sutherland F, Hemming A, Wei A, et al. Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process. J Surg Res. 2009;156:32–8.CrossRefPubMed Dixon E, Armstrong C, Maddern G, Sutherland F, Hemming A, Wei A, et al. Development of quality indicators of care for patients undergoing hepatic resection for metastatic colorectal cancer using a Delphi process. J Surg Res. 2009;156:32–8.CrossRefPubMed
40.
go back to reference Helmer O, Rescher N. On the epistemology of the inexact science. Management Sci. 1959;6:25–53.CrossRef Helmer O, Rescher N. On the epistemology of the inexact science. Management Sci. 1959;6:25–53.CrossRef
Metadata
Title
Early recognition of methicillin-resistant Staphylococcus aureus surgical site infections using risk and protective factors identified by a group of Italian surgeons through Delphi method
Authors
G. Sganga
C. Tascini
E. Sozio
S. Colizza
Publication date
01-12-2017
Publisher
BioMed Central
Published in
World Journal of Emergency Surgery / Issue 1/2017
Electronic ISSN: 1749-7922
DOI
https://doi.org/10.1186/s13017-017-0136-3

Other articles of this Issue 1/2017

World Journal of Emergency Surgery 1/2017 Go to the issue